EUVIMEDEUVIMED entdecken
Crossref

The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD

Thiago Meneses Araújo Leite Sales, Ananda Moara Lima Daniel, Lara Mara Gomes da Silva, Alvaro Xavier Franco, Humberto Barbosa da Costa Filho, Carlos Eduardo da Silva Monteiro iD, Antonia Beatriz Alves Ferreira, Sarah Antonieli Carneiro Alicrim, Antonielle de Sousa Lopes iD, Marco Antonio de Freitas Clementino iD, Antonio Carlos Pereira de Oliveira iD, Lucas Antonio Duarte Nicolau iD und 5 weitere

American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.06.2026 · 330 (6) · G718-G726

DOI: 10.1152/ajpgi.00058.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.06.2026. Verfasst von Thiago Meneses Araújo Leite Sales und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinic Medicine, Federal University of Ceará, Fortaleza, Brazil. Hauptthemen laut MEDLINE: Darunavir, Gastroesophageal Reflux, Esophagitis, Esophagus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technologic…, Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gastroesophageal reflux of pepsin contributes importantly to esophageal damage in patients with GERD. We have found that darunavir, a drug presently used to treat HIV, inhibits pepsin activity and, in an animal model of GERD, darunavir reduces esophageal inflammation and HIF-2α levels while preserving levels of tight junction proteins and esophageal mucosal integrity. These findings suggest that darunavir might have a role as a novel treatment for GERD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DarunavirGastroesophageal RefluxEsophagitisEsophagusEsophageal MucosaAnimalsDisease Models, AnimalMiceMaleEndothelial PAS Domain-Containing Protein 1OccludinZonula Occludens-1 ProteinPeroxidaseCytokines

Stichwörter der Autor:innen

HIF-2αdarunavirgastroesophageal reflux diseasepepsin

Substanzen

DarunavirEndothelial PAS Domain-Containing Protein 1OccludinZonula Occludens-1 ProteinPeroxidaseCytokines

Autor:innen und Institutionen

  • Department of Clinic Medicine, Federal University of Ceará, Fortaleza, Brazil.
  • Department of Medicine, Federal University of Delta do Parnaíba, Parnaíba, Brazil.
  • Baylor University Medical Center and Center for Esophageal Research, Dallas, Texas, United States.

ORCID-Profile: Carlos Eduardo da Silva Monteiro, Antonielle de Sousa Lopes, Marco Antonio de Freitas Clementino, Antonio Carlos Pereira de Oliveira, Lucas Antonio Duarte Nicolau, Alexandre Havt, Stuart Jon Spechler, Marcellus Henrique Loiola Ponte de Souza

Förderung

  • Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technologic…
  • Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Sales, T. M. A. L., Daniel, A. M. L., Silva, L. M. G. D., Franco, A. X., Costa Filho, H. B. D., Monteiro, C. E. D. S., Ferreira, A. B. A., Alicrim, S. A. C., Lopes, A. S., Clementino, M. A. F., Oliveira, A. C. P., Nicolau, L. A. D., Havt, A., Soares, P. M. G., Spechler, S. J., Souza, R. F., & Souza, M. H. L. P. (2026). The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD. American Journal of Physiology-Gastrointestinal and Liver Physiology, 330(6), G718-G726. https://doi.org/10.1152/ajpgi.00058.2025

Vancouver

Sales TMAL, Daniel AML, Silva LMGD, Franco AX, Costa Filho HBD, Monteiro CEDS, et al. The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2026;330(6):G718-G726. doi:10.1152/ajpgi.00058.2025

BibTeX
@article{Sales2026,
  author = {Sales, Thiago Meneses Araújo Leite and Daniel, Ananda Moara Lima and Silva, Lara Mara Gomes da and Franco, Alvaro Xavier and Costa Filho, Humberto Barbosa da and Monteiro, Carlos Eduardo da Silva and Ferreira, Antonia Beatriz Alves and Alicrim, Sarah Antonieli Carneiro and Lopes, Antonielle de Sousa and Clementino, Marco Antonio de Freitas and Oliveira, Antonio Carlos Pereira de and Nicolau, Lucas Antonio Duarte and Havt, Alexandre and Soares, Pedro Marcos Gomes and Spechler, Stuart Jon and Souza, Rhonda Frances and Souza, Marcellus Henrique Loiola Ponte de},
  title = {The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2026},
  volume = {330},
  number = {6},
  pages = {G718--G726},
  doi = {10.1152/ajpgi.00058.2025}
}
Kostenlos starten →